REG - Umuthi Healthcare - Financial statements years ending Feb 2019 & 2020

VeradigmAnnouncement

12/05/2021 19:35

RNS Number : 4519Y
  
Umuthi Healthcare Solutions PLC
  
12 May 2021
  
 

12 May 2021
Umuthi Healthcare Solutions Plc
("Umuthi" or the "Company" or the "Group")
Financial statements for the years ending 28 February 2019 and 29 February 2020 incorporating updated audit reports
 
Shareholders are referred to the RNS dated 10 May 2021 - Further Corporate Update, in which the Company updated the market on the status of statutory audited financials and the auditors' changes.
The Company herein presents the Audited Financial Statements for Umuthi Healthcare Solutions & Lems Pharmaceutical Limited for the periods ending 28 February 2019 and 29 February 2020.
The audit report for Umuthi Healthcare Solutions as at 28 February 2019 was signed off by the auditors Jeffreys Henry on 20 April 2021, please find the full statement for the year ending 28 February 2019 on https://umuthiplc.com/investors/financial-reports/audited-annual-report-2019/. The audit report for 29 February 2020 was signed off by Jeffreys Henry on 21 April 2021, please find the full statement for the year ending 29 February 2020 on https://umuthiplc.com/investors/financial-reports/audited-annual-report-2020/.
The audit reports for Lems Pharmaceutical Limited as at 28 February 2019 and 29 February 2020 were signed off by the auditors Mrwebi Auditors and Accountants Inc on 7 May 2021. Please find the full statement on https://umuthiplc.com/investors/financial-reports/lems-pharmaceutical-limited-annual-reports-2019-2020/.
These financials are released, with no changes to previous amounts and disclosures, due to the fact that the audit reports, as signed by the new auditors, were signed after the Company's admission to trading.
 
Enquiries:
 



Umuthi Healthcare Solutions Plc
Gert Viljoen, Chief Executive Officer 


Via IFC




 
IFC Advisory Ltd
Graham Herring
Zach Cohen                                                  


 
Tel: +44 (0) 20 3934 6630



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCBRGDUGXBDGBD